Understanding Tugain Solution 5% Cipla
Tugain Solution 5% represents a pharmaceutical-grade minoxidil formulation manufactured by Cipla, designed specifically for laboratory research applications. Minoxidil is a potent vasodilator that functions as a peripheral vasodilator through ATP-sensitive potassium channel activation. Researchers at Stroid UK Shop investigate this compound’s mechanism in cardiovascular physiology studies and dermatological research models. The 5% concentration provides standardised dosing for reproducible experimental protocols across multiple research paradigms.
Laboratory Applications
Research scientists examine Tugain Solution 5% in various experimental contexts, including vascular smooth muscle studies and follicular biology investigations. The compound’s vasodilatory properties make it valuable for cardiovascular research, while its documented effects on hair follicle miniaturisation reversal provide insights for dermatological studies. Investigators studying cardiovascular drugs frequently utilise this formulation in controlled laboratory environments. The topical solution format enables precise application methodologies for tissue culture work and ex-vivo organ studies. Researchers also investigate potential synergistic effects when combined with other compounds from our SARMs collection or peptides range in comprehensive research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Minoxidil 5% |
| Manufacturer | Cipla |
| Form | Topical Solution |
| CAS Number | 38304-91-5 |
| Molecular Formula | C₉H₁₅N₅O |
| Molecular Weight | 209.25 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Grade | Pharmaceutical standard |
Compliance Statement
Tugain Solution 5% is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. All studies must be conducted by qualified research personnel in appropriately licensed laboratory facilities with proper safety protocols.
